Patheon propels itself into US biologics market in Gallus acquisition
Patheon has acquired Gallus BioPharmaceuticals adding two US biologics plants and says with an industry shift towards medium sized bioreactors it now holds the market advantage.
Archives for August 26, 2014
Yearning for Yen? Merck Millipore bids to boost Japanese biz with test centre
Merck Millipore has set out to win more biomanufacturing business in Japan by consolidating testing and technical operations in the country into a newly expanded Tokyo training hub.